Contents
pdf Download PDF
pdf Download XML
50 Views
15 Downloads
Share this article
Research Article | Volume 18 Issue 11 (November, 2026) | Pages 257 - 264
Clinical outcomes of upper gastrointestinal bleeding and endoscopic interventions in a resource-limited tertiary care setting
 ,
 ,
 ,
 ,
 ,
1
Combined Military Hospital (CMH), Peshawar, Pakistan
2
Combined Military Hospital (CMH), Peshawar, Pakistan.
3
Combined Military Hospital (CMH), Peshawar, Pakistan,
4
Pak Emirates Military Hospital (PEMH), Rawalpindi, Pakistan
5
Combined Military Hospital (CMH), Peshawar, Pakistan,.
6
Combined Military Hospital, Rawalpindi, Pakistan
Under a Creative Commons license
Open Access
Received
Oct. 15, 2026
Revised
Oct. 22, 2026
Accepted
Nov. 3, 2026
Published
Nov. 16, 2026
Abstract

Introduction: Bleeding from the upper gastrointestinal tract (UGIB) is a frequent emergency in which rapid evaluation and treatment are needed to reduce complications and deaths. Over time, care has shifted away from surgery and toward endoscopic therapy, a change that matters most in low-resource hospitals where surgical capacity is limited. Aim: We set out to characterize patients treated for UGIB at a tertiary hospital in Peshawar, Pakistan, from January 2024 to December 2025 in terms of presentation, bleeding source, endoscopic treatment, and outcomes, and to determine which factors predicted admission to the intensive care unit (ICU). Methods: In this retrospective review, we analyzed 235 patients who had endoscopy for UGIB, using demographic, clinical, etiological, and treatment data taken from hospital records. Rebleeding within 4 weeks, in-hospital death, and readmission within 30 days were the primary outcomes; ICU admission, hospital stay, transfusion requirement, repeat endoscopy, interventional radiology (IR), and surgery were secondary outcomes. Predictors of ICU admission were examined with binary logistic regression. Results: Patients had a mean age of 45.5 ± 17.1 years, and 61.3% were men. Duodenal ulcer was the single most frequent bleeding source (28.1%), whereas gastric and esophageal varices together accounted for 40.9% of cases. The commonest procedures were band ligation (19.6%), adrenaline injection (16.2%), and hemoclip placement (12.8%). Rebleeding within 4 weeks affected 18.7% of patients and occurred more often with variceal than with non-variceal bleeding (28.1% vs. 12.2%, p = 0.004). Readmission within 30 days occurred in 16.6%, again more often after variceal bleeding (32.3% vs. 5.8%, p < 0.001). Repeat endoscopy was performed in 15.3%, IR in 1.7%, and surgery in 0.9%. ICU care was needed in 23.4%; on average, patients stayed 5.31 ± 2.60 days and received 2.17 ± 1.72 units of packed red cells, and 1.3% died in hospital. On multivariable analysis, ICU admission was more likely with lower admission hemoglobin (OR 0.68; 95% CI 0.52–0.89; p = 0.004), faster heart rate (OR 1.03; 95% CI 1.01–1.05; p = 0.013), variceal etiology (OR 2.25; 95% CI 1.16–4.37; p = 0.017), and female sex (OR for male sex 0.46; 95% CI 0.24–0.89; p = 0.020). Conclusion: In this resource-limited tertiary care setting, an endoscopy-based approach to UGIB was associated with low rates of surgery, IR, and in-hospital death. Variceal bleeding formed the highest-risk group, with more rebleeding and readmission, pointing to the need for structured secondary prophylaxis and follow-up. Admission hemoglobin and heart rate are simple bedside measures that may help identify patients who need intensive care.

Keywords
INTRODUCTION

Acute bleeding from the upper gastrointestinal tract (UGIB) ranks among the commonest emergencies in gastroenterology. It carries a considerable burden of morbidity, recurrent bleeding, blood transfusion, prolonged hospitalization, and death. Presentation ranges from minor mucosal oozing to massive hemorrhage with hemodynamic instability, so prompt resuscitation, risk assessment, and timely endoscopy are the core of modern management. Guidelines now advise that upper endoscopy be carried out within the first 24 hours after presentation, once the patient is hemodynamically stable, and that lesions with high-risk stigmata be treated endoscopically [1–3].

 

Approaches to UGIB have evolved markedly in recent decades. Patients with uncontrolled or recurrent bleeding, particularly from peptic ulcers or large varices, were once treated mainly with surgery. Endoscopy has since become the principal therapeutic tool, and care is now largely endoscopy-centered [2–5]. For most patients, endoscopic hemostasis is now the initial treatment of choice, using adrenaline injection, hemoclips, band ligation, sclerotherapy, thermal coagulation, or a combination of these. In non-variceal bleeding, repeat endoscopy is the usual first step when bleeding recurs; transcatheter arterial embolization is reserved for cases in which endoscopy fails or is unavailable, and surgery for patients in whom other options have failed [5–8].

 

This shift is particularly relevant to resource-limited tertiary care hospitals, where surgical care is constrained by limited operating room time, higher perioperative risk, cost, late presentation, and shortages of specialist staff. Previous studies indicate that an efficiently run emergency endoscopy service can lower the need for surgery in these settings [8–11]. Interventional radiology (IR) provides a further minimally invasive rescue option, but in many low- and middle-income countries it is not readily available [12]. Real-world data on the outcomes of endoscopic management in resource-constrained hospitals are therefore needed to guide service planning and reduce UGIB-related morbidity and mortality [13]. National audits further suggest that how endoscopy services are organized, for example whether endoscopy is available after hours and whether standard endoscopic therapy is applied consistently, influences the quality of UGIB care [14].

 

Our objectives were to profile patients treated for UGIB at our hospital in terms of their background and presentation, to identify the leading causes of bleeding, to document the endoscopic treatments used, and to assess rebleeding, in-hospital death, readmission within 30 days, intensive care unit (ICU) admission, repeat endoscopy, IR, and surgery. A further aim was to determine which factors were independently related to ICU admission. Such local data may help reduce reliance on surgery and strengthen UGIB care pathways in similar resource-limited settings.

MATERIAL AND METHODS

Study Design and Setting

This retrospective observational study was carried out at a tertiary care hospital in Peshawar, Pakistan, using records for the period between January 2024 and December 2025. Over these 2 years, the hospital performed 1,152 upper gastrointestinal endoscopies.

 

Participants

Patients qualified for inclusion if they were 16 years of age or older, had been admitted with UGIB, and had undergone upper endoscopy. Those with suspected lower gastrointestinal bleeding or incomplete outcome data were excluded, which left 235 patients for analysis.

 

Data Collection and Definitions

From hospital records, we obtained demographics, presenting features (melena, hematemesis, and heart rate), admission hemoglobin, endoscopic findings, treatment, blood transfusion, and outcomes. A heart rate of more than 100 beats per minute (bpm) was considered tachycardia. The bleeding source was recorded as variceal (esophageal or gastric varices), peptic ulcer (duodenal or gastric), Mallory–Weiss tear, esophagitis, Dieulafoy lesion, angiodysplasia, or gastric malignancy. For comparative analyses, esophageal and gastric varices were grouped together as variceal bleeding.

All patients underwent endoscopy. Endoscopic treatment was chosen according to the lesion found and included adrenaline injection, hemoclips, heater probe thermocoagulation, band ligation, cyanoacrylate injection, argon plasma coagulation (APC), and combination therapy. Selected patients with variceal bleeding also received intravenous terlipressin, either alone or with band ligation.

 

Outcomes

Three primary outcomes were assessed: rebleeding, death in hospital, and readmission within 30 days. Rebleeding meant a clinically significant recurrence of bleeding after initial hemostasis had been achieved, occurring up to 4 weeks after the index endoscopy. In-hospital mortality covered deaths from any cause before discharge from the index admission, and readmission covered any unplanned return to hospital within 30 days of discharge. As secondary outcomes, we recorded ICU admission, duration of hospitalization, the number of red cell units transfused, repeat endoscopy, IR intervention, and surgery.

 

Statistical Analysis

Statistical analyses were run in IBM SPSS Statistics (version 27.0; IBM Corp., Armonk, NY, USA), and figures were produced in Python (version 3.13) with the Matplotlib library (version 3.11). Continuous data are summarized as mean ± standard deviation (SD), with median and interquartile range (IQR) added where helpful, and categorical data as number and percentage. Because several continuous variables were skewed, nonparametric tests were applied: the Mann–Whitney U test when two groups were compared, and the Kruskal–Wallis H test when three or more were compared. Categorical comparisons used the chi-square test with Yates’ correction, replaced by Fisher’s exact test whenever an expected cell frequency was less than 5. The strength of the relationship between admission hemoglobin and units transfused was expressed as Pearson’s r.

Independent predictors of ICU admission were identified with a binary logistic regression model, into which six covariates (age, admission hemoglobin, heart rate, units transfused, variceal etiology, and sex) were entered simultaneously. Associations are expressed as odds ratios (ORs) and accompanying 95% confidence intervals (CIs). The omnibus chi-square test, Nagelkerke R2, and the Hosmer–Lemeshow test were used to evaluate the model. Missing values were not imputed, so only patients with complete covariate data contributed to the model. Each outcome was additionally compared between the variceal and non-variceal bleeding groups. Significance was set at a two-sided p < 0.05.

 

Ethical Considerations

Ethical approval for the study was granted by the Ethical Review Committee for Medical and Biomedical Research, Combined Military Hospital, Peshawar, Pakistan (approval No. 284/2026). Records were anonymized before any analysis.

RESULTS

Demographic and Baseline Characteristics

Over the 2-year period, 235 patients with acute UGIB were studied: 144 men (61.3%) and 91 women (38.7%), giving a male-to-female ratio of 1.58:1 (Table 1). Their mean age was 45.5 ± 17.1 years (median 47 years, IQR 32–56; range 16–85).

The mean heart rate at admission was 102.0 ± 17.3 bpm, and 126 of the 230 patients with a recorded pulse (54.8%) were tachycardic. Mean admission hemoglobin was 8.24 ± 2.08 g/dL, indicating moderate anemia on average. Because the data were collected retrospectively, hemoglobin was missing for 12 patients (5.1%) and pulse for 5 (2.1%). Melena was the most common presenting feature (n = 142, 60.4%), followed by hematemesis (n = 137, 58.3%); at least 44 patients had both.

 

Table 1. Characteristics of Patients at Presentation (N = 235).

Characteristic

Value

Missing, n (%)

Demographics

Age, years, M ± SD

45.5 ± 17.1

0 (0.0)

   Median [IQR]

47 [32–56]

—

   Range

16–85

—

Male sex, n (%)

144 (61.3)

0 (0.0)

Female sex, n (%)

91 (38.7)

0 (0.0)

Clinical presentation

Hemoglobin on admission, g/dL, M ± SD

8.24 ± 2.08

12 (5.1)

Heart rate, bpm, M ± SD

102.0 ± 17.3

5 (2.1)

Tachycardia (>100 bpm), n (%) a

126 (54.8)

5 (2.1)

Melena, n (%)

142 (60.4)

0 (0.0)

Hematemesis, n (%)

137 (58.3)

0 (0.0)

Note. Data are presented as mean ± SD, median [IQR], or n (%). IQR, interquartile range; bpm, beats per minute. a Percentage of patients with a recorded heart rate (n = 230).

 

Etiology of Upper Gastrointestinal Bleeding

The leading single cause of bleeding was duodenal ulcer (n = 66, 28.1%), followed by gastric varices (n = 51, 21.7%) and esophageal varices (n = 45, 19.1%) (Table 2). Taken together, variceal bleeding accounted for 96 cases (40.9%), making it the largest etiological group. Gastric ulcer (n = 27, 11.5%) and Mallory–Weiss tear (n = 22, 9.4%) were the next most frequent causes. Less common causes were esophagitis (n = 8, 3.4%), Dieulafoy lesion (n = 6, 2.6%), angiodysplasia (n = 5, 2.1%), and gastric malignancy (n = 5, 2.1%).

Admission hemoglobin differed significantly across etiological groups (Kruskal–Wallis H(8) = 15.70, p = 0.047).

 

Table 2. Distribution of Bleeding Sources (N = 235).

Etiology

n

%

Cumulative %

Duodenal ulcer

66

28.1

28.1

Gastric varices

51

21.7

49.8

Esophageal varices

45

19.1

68.9

Gastric ulcer

27

11.5

80.4

Mallory–Weiss tear

22

9.4

89.8

Esophagitis

8

3.4

93.2

Dieulafoy lesion

6

2.6

95.7

Angiodysplasia

5

2.1

97.9

Gastric malignancy

5

2.1

100.0

Total

235

100.0

—

Note. Variceal bleeding (gastric and esophageal varices combined) accounted for 96 cases (40.9%).

Endoscopic Interventions

All patients underwent diagnostic endoscopy, and treatment was tailored to the lesion found (Table 3). Band ligation was the most frequent procedure (n = 46, 19.6%) and was used mainly for esophageal variceal bleeding. Adrenaline injection was used in 38 patients (16.2%) with peptic ulcers that were actively bleeding or carried signs of recent bleeding; hemoclips were applied in 30 (12.8%), and adrenaline injection combined with heater probe thermocoagulation in 24 (10.2%). The six patients (2.6%) with a Dieulafoy lesion received adrenaline injection plus hemoclips.

 

Among patients with variceal bleeding, 18 (7.7% of the cohort) received cyanoacrylate injection for gastric varices, 16 (6.8%) received band ligation with intravenous terlipressin for active bleeding with hemodynamic compromise, and 16 (6.8%) received intravenous terlipressin alone. Twenty-three patients (9.8%), mostly with Mallory–Weiss tears or esophagitis in whom spontaneous hemostasis was expected, were managed conservatively after endoscopic assessment, and a further 10 hemodynamically stable patients (4.3%) required no specific intervention. APC was used in 5 patients (2.1%) with angiodysplasia, and palliative APC in 3 (1.3%) with gastric malignancy.

 

Table 3. Endoscopic and Therapeutic Interventions (N = 235).

Intervention

n

%

Main indication

Band ligation

46

19.6

Esophageal varices

Adrenaline injection

38

16.2

Peptic ulcer

Hemoclip application

30

12.8

Peptic ulcer

Adrenaline + heater probe

24

10.2

Actively bleeding ulcer

Conservative management

23

9.8

Mallory–Weiss tear, esophagitis

Cyanoacrylate injection

18

7.7

Gastric varices

Band ligation + IV terlipressin

16

6.8

Active variceal bleeding

IV terlipressin alone

16

6.8

Gastric varices

No intervention

10

4.3

Hemodynamically stable

Adrenaline + hemoclip

6

2.6

Dieulafoy lesion

APC

5

2.1

Angiodysplasia

Palliative APC

3

1.3

Gastric malignancy

Total

235

100.0

—

Note. Percentages are of the total cohort. Band ligation includes procedures for both esophageal and gastric varices. Conservative management refers to endoscopic assessment followed by medical therapy alone; no intervention refers to hemodynamically stable patients who required no specific treatment. APC, argon plasma coagulation; IV, intravenous.

 

Blood Transfusion Requirements

On average, patients received 2.17 ± 1.72 units of packed red cells (range 0–8). The higher the admission hemoglobin, the fewer units were transfused, a strong inverse association (r = −0.713, p < 0.001; Figure 1B).

 

Clinical Outcomes

ICU admission. Fifty-five patients (23.4%) required ICU admission. Compared with patients managed on the ward, they had a lower mean admission hemoglobin (7.55 ± 2.14 g/dL vs. 8.46 ± 2.03 g/dL; p = 0.012) and a faster heart rate (109.4 ± 18.1 bpm vs. 99.8 ± 16.6 bpm; p < 0.001; Table 4). ICU admission rates were 28.1% in variceal and 20.1% in non-variceal bleeding, a difference that was not statistically significant on univariable analysis (χ2(1) = 1.60, p = 0.206). After adjustment for other covariates, however, variceal etiology was independently associated with ICU admission (see below).

 

Length of stay. Patients spent a mean of 5.31 ± 2.60 days in hospital. Those admitted to the ICU stayed significantly longer than ward patients (7.98 ± 2.71 vs. 4.48 ± 2.06 days, p < 0.001; Figure 1A). Length of stay also differed across the five most frequent etiological groups (Kruskal–Wallis H(4) = 13.27, p = 0.010).

 

Rebleeding. Forty-four patients (18.7%) rebled within 4 weeks. Rebleeding was more frequent in variceal than in non-variceal bleeding (28.1% vs. 12.2%; χ2(1) = 8.41, p = 0.004). Rebleeding rates were 29.4% for gastric varices and 26.7% for esophageal varices, compared with 18.2% for duodenal ulcer, 11.1% for gastric ulcer, and 4.5% for Mallory–Weiss tear (Figure 1C).

 

Readmission. Thirty-nine patients (16.6%) were readmitted within 30 days. Readmission was considerably more common after variceal bleeding (32.3% vs. 5.8%; χ2(1) = 27.00, p < 0.001).

 

Repeat endoscopy, interventional radiology, and surgery. Repeat endoscopy was required in 36 patients (15.3%), IR intervention in 4 (1.7%), and surgery in 2 (0.9%).

 

In-hospital mortality. Three patients (1.3%) died in hospital. All three had severe hemodynamic compromise at presentation and required ICU admission; two had variceal bleeding and one had a non-variceal source. Mortality was therefore higher among ICU patients (5.5% vs. none on the ward; p = 0.012, Fisher’s exact test).

 

Table 4. Clinical Characteristics and Outcomes by ICU Admission Status.

Variable

Total (N = 235)

ICU (n = 55)

Ward (n = 180)

p

 

Continuous variables

Hemoglobin, g/dL

8.24 ± 2.08

7.55 ± 2.14

8.46 ± 2.03

0.012*

 

Heart rate, bpm

102.0 ± 17.3

109.4 ± 18.1

99.8 ± 16.6

<0.001**

 

Units transfused

2.17 ± 1.72

2.58 ± 1.84

2.04 ± 1.67

0.151

 

Hospital stay, days

5.31 ± 2.60

7.98 ± 2.71

4.48 ± 2.06

<0.001**

 

Categorical variables

Rebleeding within 4 weeks

44 (18.7)

18 (32.7)

26 (14.4)

0.004*

 

Readmission within 30 days

39 (16.6)

16 (29.1)

23 (12.8)

0.008*

 

In-hospital mortality

3 (1.3)

3 (5.5)

0 (0.0)

0.012*a

 

Note. Values are given as mean ± SD or n (%). Continuous variables were tested with the Mann–Whitney U test and categorical variables with the Yates-corrected chi-square test, except where indicated. ICU, intensive care unit; bpm, beats per minute. a Fisher’s exact test. * p < 0.05. **p < 0.001.

Predictors of ICU Admission

Overall, the regression model was significant (χ2(6) = 25.65, p < 0.001; Nagelkerke R2 = 0.16), and calibration was acceptable (Hosmer–Lemeshow p = 0.622). Table 5 shows the four variables that remained independently associated with ICU admission. For every 1 g/dL rise in admission hemoglobin, the odds of ICU admission fell by 32% (OR 0.68; 95% CI 0.52–0.89; p = 0.004); conversely, every 1 g/dL drop raised the odds by roughly 47%. The odds increased by about 2.5% with each additional beat per minute of heart rate (OR 1.03; 95% CI 1.01–1.05; p = 0.013) and were more than twice as high with variceal etiology (OR 2.25; 95% CI 1.16–4.37; p = 0.017). Men had lower odds of ICU admission than women (OR 0.46; 95% CI 0.24–0.89; p = 0.020). Neither age nor units transfused predicted ICU admission.

 

Table 5. Multivariable Predictors of ICU Admission (Binary Logistic Regression).

Predictor

B

OR

95% CI

Wald χ2

p

Age (per year)

−0.006

0.994

0.974–1.015

0.30

0.582

Hemoglobin (per g/dL)

−0.388

0.68

0.52–0.89

8.13

0.004*

Heart rate (per bpm)

0.025

1.03

1.01–1.05

6.14

0.013*

Units transfused (per unit)

−0.174

0.84

0.64–1.11

1.52

0.218

Variceal etiology

0.810

2.25

1.16–4.37

5.71

0.017*

Male sex

−0.775

0.46

0.24–0.89

5.39

0.020*

Note. Model χ2(6) = 25.65, p < 0.001; Nagelkerke R2 = 0.16; Hosmer–Lemeshow p = 0.622. Non-variceal etiology and female sex served as the reference categories. B, regression coefficient; OR, odds ratio; CI, confidence interval; ICU, intensive care unit; bpm, beats per minute. * p < 0.05.

Comparison by Bleeding Source

Of the 235 patients, 96 (40.9%) had variceal and 139 (59.1%) had non-variceal bleeding (Table 6). Rebleeding (χ2(1) = 8.41, p = 0.004) and readmission (χ2(1) = 27.00, p < 0.001) were both significantly more frequent in the variceal group. By contrast, the two groups were similar in ICU admission (28.1% vs. 20.1%; p = 0.206), hospital stay (5.84 ± 2.91 vs. 4.95 ± 2.34 days; p = 0.082), units transfused (2.44 ± 1.81 vs. 1.99 ± 1.63; p = 0.148), and in-hospital mortality (2.1% vs. 0.7%; p = 0.569).

 

Table 6. Clinical Outcomes Stratified by Bleeding Source.

Outcome

Variceal
(n = 96)

Non-variceal
(n = 139)

Test statistic

p

ICU admission, n (%)

27 (28.1)

28 (20.1)

χ2(1) = 1.60

0.206

Hospital stay, days, M ± SD

5.84 ± 2.91

4.95 ± 2.34

U = 5,821

0.082

Rebleeding within 4 weeks, n (%)

27 (28.1)

17 (12.2)

χ2(1) = 8.41

0.004*

Readmission within 30 days, n (%)

31 (32.3)

8 (5.8)

χ2(1) = 27.00

<0.001**

In-hospital mortality, n (%)

2 (2.1)

1 (0.7)

Fisher’s exact

0.569

Units transfused, M ± SD

2.44 ± 1.81

1.99 ± 1.63

U = 5,925

0.148

Note. Continuous outcomes were compared by two-tailed Mann–Whitney U tests; categorical outcomes by the chi-square test with Yates’ correction or, if any expected count was below 5, by Fisher’s exact test. ICU, intensive care unit. * p < 0.05. ** p < 0.001.

DISCUSSION

UGIB is a potentially life-threatening condition, and delays in diagnosis or treatment can have serious consequences. This study shows the central role of endoscopy in managing UGIB in a resource-limited tertiary care setting. All 235 patients underwent endoscopy, which served as both the main diagnostic and the main therapeutic tool, in keeping with the wider move toward endoscopy-first management.

 

The endoscopic techniques used included adrenaline injection, hemoclips, band ligation, cyanoacrylate injection, APC, and combination therapy. Repeat endoscopy was needed in 15.3% of patients, IR in 1.7%, and surgery in only 0.9%. This low surgical rate is consistent with earlier reports that therapeutic endoscopy reduces the need for surgery in UGIB [13,15]. Because the study had no comparison group, however, the low surgical rate cannot be attributed to endoscopic therapy alone.

 

The rebleeding rate of 18.7% was higher than the 13% reported in the 2007 UK national audit [16]. The most likely explanation is the high proportion of variceal bleeding in our cohort (40.9%; gastric varices 21.7%, esophageal varices 19.1%). As in previous work, patients with varices rebled significantly more often than those with non-variceal lesions, consistent with the higher risk of recurrence associated with portal hypertension and chronic liver disease [5]. Our 4-week follow-up window, which captures events after discharge, may also have produced a higher rate than studies that report in-hospital rebleeding only.

 

Timely endoscopy is central to the management of UGIB. The guideline of the European Society of Gastrointestinal Endoscopy (Gralnek et al.) advises performing endoscopy within 24 hours of presentation once the patient has been resuscitated, so that the bleeding source can be identified and treated promptly and more invasive interventions avoided [17]. Every patient in our cohort had endoscopy during the index admission; however, we did not assess whether the timing of endoscopy influenced outcomes.

 

Almost a quarter of patients (23.4%) required ICU admission. Compared with ward patients, they had lower hemoglobin and faster heart rates, stayed in hospital longer, rebled more often, and were more likely to die. After multivariable adjustment, lower hemoglobin, higher heart rate, and variceal etiology were independently associated with ICU admission. These are simple bedside variables that could help identify high-risk patients early, although they should complement rather than replace validated tools such as the Glasgow–Blatchford score. Variceal etiology was not significantly associated with ICU admission in the unadjusted comparison but became significant after adjustment, suggesting that group imbalances in hemoglobin, heart rate, and sex had obscured the unadjusted association. The finding that women had higher adjusted odds of ICU admission was unexpected and needs cautious interpretation; unmeasured differences in comorbidity, bleeding severity, or referral patterns could explain it.

 

The mean admission hemoglobin was 8.24 g/dL, and the mean transfusion requirement was 2.17 units. As expected, lower admission hemoglobin was strongly associated with a greater transfusion requirement, which supports early assessment of anemia severity in patients with UGIB.

 

IR was rarely used (1.7%). Transcatheter arterial embolization is an effective rescue option when endoscopic hemostasis fails [18], but its availability in low- and middle-income settings is limited by a lack of trained interventional radiologists, equipment, and funding [12]. The low rate of IR in our cohort probably reflects both effective endoscopic control and this limited access, and it suggests that endoscopic therapy, as recommended by current guidelines, was sufficient for most patients [17,19].

 

In-hospital mortality was low (1.3%), well below the 10% reported in the 2007 UK national audit [16]. All three deaths occurred in patients with severe hemodynamic instability who required ICU care. This is consistent with the Rockall risk model, in which shock, age, and comorbidity are among the main predictors of death after UGIB, and it suggests that disease severity at presentation, rather than failure of endoscopic treatment alone, was the main determinant of mortality [20]. The low mortality should, however, be read in light of the relatively young cohort (mean age 45.5 years) and the fact that deaths were recorded only during the index admission.

 

Overall, these findings support the role of therapeutic endoscopy in managing UGIB in this setting. Surgery and IR were rarely needed, and outcomes were generally favorable for both variceal and non-variceal sources. Even so, the variceal group continued to face a greater risk of rebleeding and readmission. The high readmission rate in this group may reflect the chronic, relapsing course of portal hypertension and possible gaps in secondary prophylaxis after discharge. These patients require close follow-up, with repeat endoscopy and band ligation when needed, suitable drug therapy, and long-term secondary prevention using non-selective beta-blockers combined with endoscopic surveillance [5,21].

 

Our study has some limitations. Being retrospective and conducted at a single center, it may not be generalizable to other settings, and it depends on the completeness of documentation; admission hemoglobin and pulse were missing for some patients. Second, without a comparison group, we cannot establish that endoscopic therapy caused the low rates of surgery and death. Third, we could not calculate validated risk scores (Glasgow–Blatchford or Rockall), and comorbidities and the timing of endoscopy were not analyzed. Fourth, the regression model included units transfused, a treatment variable that is strongly correlated with admission hemoglobin and may itself follow the decision to admit a patient to the ICU; with 55 events and six predictors, the model may also be prone to overfitting. Fifth, the small number of deaths did not allow analysis of mortality predictors. Finally, readmissions to other hospitals may have been missed. Despite these limitations, the study provides real-world data on UGIB management and outcomes from a resource-limited setting in Pakistan, where such data remain scarce.

 

CONCLUSION

Therapeutic endoscopy was the cornerstone of UGIB management in this resource-limited tertiary care center. All 235 patients underwent endoscopic evaluation, and treatment with band ligation, adrenaline injection, hemoclips, thermal coagulation, or combination therapy was accompanied by low rates of surgery (0.9%) and IR (1.7%). In-hospital mortality was 1.3%, despite marked anemia and frequent tachycardia at presentation.

 

Variceal bleeding accounted for 40.9% of cases and was associated with significantly higher rates of rebleeding and readmission than non-variceal bleeding. Lower hemoglobin, higher heart rate, variceal etiology, and female sex were independent predictors of ICU admission. These findings support early risk stratification and close follow-up, including structured secondary prophylaxis, for patients with variceal bleeding. Confirmation in prospective multicenter studies that use validated risk scores is still required.

REFERENCES
  1. Sourabh S, Sharma N, Sharma R, Kumar R, Thakur S, Bodh V, et al. Clinical profile, severity and outcome of acute upper gastrointestinal bleeding in elderly patients compared to non-elderly patients: a prospective observational study. J Assoc Physicians India. 2019;67:30–2. PMID: 31561685.
  2. Lanas A, Dumonceau JM, Hunt RH, et al. Non-variceal upper gastrointestinal bleeding. Nat Rev Dis Primers. 2018;4:18020. doi:10.1038/nrdp.2018.20
  3. Barkun AN, Almadi M, Kuipers EJ, et al. Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group. Ann Intern Med. 2019;171:805–22. doi:10.7326/M19-1795
  4. Lau JY, Yu Y, Tang RS, et al. Timing of endoscopy for acute upper gastrointestinal bleeding. N Engl J Med. 2020;382:1299–308. doi:10.1056/NEJMoa1912484
  5. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65:310–35. doi:10.1002/hep.28906
  6. Lazăr DC, Ursoniu S, Goldiş A. Predictors of rebleeding and in-hospital mortality in patients with nonvariceal upper digestive bleeding. World J Clin Cases. 2019;7:2687–703. doi:10.12998/wjcc.v7.i18.2687
  7. González-González JA, Monreal-Robles R, García-Compean D, Paz-Delgadillo J, Wah-Suárez M, Maldonado-Garza HJ. Nonvariceal upper gastrointestinal bleeding in elderly people: clinical outcomes and prognostic factors. J Dig Dis. 2017;18:212–21. doi:10.1111/1751-2980.12459
  8. Cagir Y, Durak MB, Yuksel I. Optimal endoscopy timing in elderly patients presenting with acute non-variceal upper gastrointestinal bleeding. BMC Gastroenterol. 2024;24:444. doi:10.1186/s12876-024-03541-z
  9. Ahmed A, Stanley AJ. Acute upper gastrointestinal bleeding in the elderly: aetiology, diagnosis and treatment. Drugs Aging. 2012;29:933–40. doi:10.1007/s40266-012-0020-5
  10. Stasik K, Ferenc K, Partyka K, Kilisiński W, Filip R. Impact of urgent versus early endoscopy on outcomes in acute upper gastrointestinal bleeding: a retrospective study. Can J Gastroenterol Hepatol. 2025;2025:4328051. doi:10.1155/cjgh/4328051
  11. Button LA, Roberts SE, Evans PA, et al. Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study. Aliment Pharmacol Ther. 2011;33:64–76. doi:10.1111/j.1365-2036.2010.04495.x
  12. Jamil H, Tariq W, Ameer MA, Asghar MS, Mahmood H, Tahir MJ, et al. Interventional radiology in low- and middle-income countries. Ann Med Surg (Lond). 2022;77:103594. doi:10.1016/j.amsu.2022.103594
  13. Chaudhary S, Mackay D, Pell JP, et al. Upper gastrointestinal bleeding in Scotland 2000–2015: trends in demographics, aetiology and outcomes. Aliment Pharmacol Ther. 2021;53:383–9. doi:10.1111/apt.16170
  14. Hearnshaw SA, Logan RFA, Lowe D, Travis SPL, Murphy MF, Palmer KR. Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit. Gut. 2010;59:1022–9.
  15. Rosenstock SJ, Møller MH, Larsson H, et al. Improving quality of care in peptic ulcer bleeding: nationwide cohort study of 13,498 consecutive patients in the Danish Clinical Register of Emergency Surgery. Am J Gastroenterol. 2013;108:1449–57. doi:10.1038/ajg.2013.162
  16. Hearnshaw SA, Logan RFA, Lowe D, Travis SPL, Murphy MF, Palmer KR. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut. 2011;60:1327–35. doi:10.1136/gut.2010.228437
  17. Gralnek IM, Stanley AJ, Morris AJ, et al. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021. Endoscopy. 2021;53:300–32. doi:10.1055/a-1369-5274
  18. Loffroy R, Favelier S, Pottecher P, Estivalet L, Genson PY, Gehin S, et al. Transcatheter arterial embolization for acute nonvariceal upper gastrointestinal bleeding: indications, techniques and outcomes. Diagn Interv Imaging. 2015;96:731–44. doi:10.1016/j.diii.2015.05.002
  19. Laine L, Barkun AN, Saltzman JR, Martel M, Leontiadis GI. ACG clinical guideline: upper gastrointestinal and ulcer bleeding. Am J Gastroenterol. 2021;116:899–917. doi:10.14309/ajg.0000000000001245
  20. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut. 1996;38:316–21. doi:10.1136/gut.38.3.316
  21. de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII – Renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74. doi:10.1016/j.jhep.2021.12.022
Recommended Articles
Research Article
Prescribing Patterns of Proton Pump Inhibitors Among Long-Term Users in a Tertiary Care Hospital: A Cross-Sectional Drug Utilization Study
Published: 13/11/2025
Research Article
Serum Vitamin B12 Status in Type 2 Diabetes Mellitus Patients Receiving Metformin: A Cross-sectional Comparative Study.
Published: 26/02/2026
Research Article
Morphological Variations of the Circle of Willis in Adult Human Cadaveric Brains: A Descriptive Study with Clinical Correlations
Published: 13/11/2025
Research Article
Comparative study of endotracheal tube cuff inflation with air versus alkalinized lidocaine on hemodynamic response during extubation.
Published: 14/11/2026
Chat on WhatsApp
© Copyright CME Journal Geriatric Medicine